Panel Discussion: India as an injectable hub: Growing CDMO strength and global partnerships

Mr Sridhar Balasubramanian, Head Quality – Sterile / Parenteral, Dr Reddy’s Laboratories

Panel Discussion: Beyond generics: Moving into complex injectables, oncology and biosimilars